Jordan, shown at a news conference last year, warns of neglecting the risks of inflation.
Keystone/Anthony Anex
The Swiss National Bank (SNB) can expand its balance sheet further if needed, says chairman of the board Thomas Jordan.
This content was published on
2 minutes
swissinfo.ch with Bloomberg agency/ug
“A big balance sheet is per se no problem. We can expand the balance sheet further, if monetary policy so requires,” he told the Neue Zürcher Zeitung newspaper in an interview published on Saturday.
The SNB’s holdings of foreign exchange have ballooned to more than CHF900 billion ($1.1 trillion) due to its long-running campaign to weaken the franc via interventions. That practice not only drew scrutiny from the United States Treasury — the central bank’s huge pile of assets also exposes it to big swings in prices.
The franc is still highly valued, and inflation is just slightly below zero, according to Jordan. Still, “we only intervene as needed.”
He also rejected focusing monetary policy more closely on the exchange rate and said there still was a lot of slack left in the economy.
“It would be completely premature to begin shrinking the balance sheet and tightening monetary conditions,” he said. “It would be wrong to signal to the world now that the SNB will be the first central bank to usher in a restrictive policy.”
Asked whether the SNB was prepared to accept an inflation rate of 2% and more, similar to the US central bank, Jordan said every country was faced with a different situation.
“History has taught us a lesson: A recession is most likely if inflation gets out of control and measures are needed to fight it.”
It’s preferable to stabilise increasing prices at a maximum rate of 2%, he added.
Swisscom receives greenlight for acquisition of Vodafone Italia
This content was published on
The takeover of Vodafone Italia by Swisscom is nearing completion. All relevant authorities have now approved the €8 billion (CHF7.45 billion) deal.
Novo Nordisk stock market plunge drags down Swiss device maker Ypsomed
This content was published on
The Danish pharmaceutical giant, Novo Nordisk, faced setbacks on Friday that weighed on the share price of Swiss injection device manufacturer Ypsomed.
Swiss press react to EU deal with mix of euphoria and scepticism
This content was published on
Swiss media reaction to the agreement between Switzerland and the EU varies widely. Some are celebrating, while others worry about what is to come.
Swiss Solidarity donations to tackle child abuse top CHF4 million
This content was published on
Swiss Solidarity, the humanitarian arm of the Swiss Broadcasting Corporation (SBC), has raised over CHF4 million ($4.3 million) to tackle child abuse.
EU Commission president says Swiss-EU deal is ‘historic’ agreement
This content was published on
At a joint media conference with Swiss President Viola Amherd in Bern, European Commission President Ursula von der Leyen spoke of a "day of joy".
Switzerland and EU reach deal on future bilateral relations
This content was published on
Switzerland and the European Union have announced a political agreement to update their trading relationship after almost a decade of difficult talks.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Swiss and US central banks: same purpose, different paths
This content was published on
Choosing members of the Federal Reserve shows organisational differences between the US central bank and the Swiss National Bank.
SNB chief commends Swiss banks for handling of Covid crisis
This content was published on
Swiss banks have so far weathered the impact of the Covid-19 pandemic well, according to Swiss National Bank chairman Thomas Jordan.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.